Literature DB >> 11864794

Measurement of fatigue. determining minimally important clinical differences.

Anna L Schwartz1, Paula M Meek, Lillian M Nail, James Fargo, Margaret Lundquist, Melissa Donofrio, Marilyn Grainger, Terry Throckmorton, Magdalena Mateo.   

Abstract

The purpose was to determine the minimally important clinical difference (MICD) in fatigue as measured by the Profile of Mood States, Schwartz Cancer Fatigue Scale (SCFS), General Fatigue Scale, and a 10-point single-item fatigue measure. The MICD is the smallest amount of change in a symptom (e.g., fatigue) measure that signifies an important change in that symptom. Subjects rated the degree of change in their fatigue over 2 days on a Global Rating Scale. 103 patients were enrolled on this multisite prospective repeated measures design. MICD was determined following established procedures at two time points. Statistically significant changes were observed for moderate and large changes in fatigue, but not for small changes. The scales were sensitive to increases in fatigue over time. The MICD, presented as mean change, for each scale and per item on each scale is: POMS = 5.6, per item = 1.1, SCFS = 5.0, per item = 0.8, GFS = 9.7, per item = 1.0, and the single item measure of fatigue was 2.4 points. This information may be useful in interpreting scale scores and planning studies using these measures.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11864794     DOI: 10.1016/s0895-4356(01)00469-3

Source DB:  PubMed          Journal:  J Clin Epidemiol        ISSN: 0895-4356            Impact factor:   6.437


  24 in total

1.  Effect of iron supplementation on fatigue in nonanemic menstruating women with low ferritin: a randomized controlled trial.

Authors:  Paul Vaucher; Pierre-Louis Druais; Sophie Waldvogel; Bernard Favrat
Journal:  CMAJ       Date:  2012-07-09       Impact factor: 8.262

2.  Psychometric properties of three instruments to measure fatigue with myocardial infarction.

Authors:  Anne M Fink; Ann L Eckhardt; Michelle M Fennessy; Jessica Jones; Donna Kruse; Kathryn J VanderZwan; Catherine J Ryan; Julie J Zerwic
Journal:  West J Nurs Res       Date:  2010-08-04       Impact factor: 1.967

3.  Exercise compliance among patients with multiple myeloma undergoing chemotherapy: a retrospective study.

Authors:  Shirin Shallwani; Mary-Ann Dalzell; Warren Sateren; Suzanne O'Brien
Journal:  Support Care Cancer       Date:  2015-03-06       Impact factor: 3.603

Review 4.  Management of fatigue in cancer patients.

Authors:  Mellar P Davis; Dilara Khoshknabi; Guang H Yue
Journal:  Curr Pain Headache Rep       Date:  2006-08

5.  Minimal clinically important improvement and patient acceptable symptom state for subjective outcome measures in rheumatic disorders.

Authors:  Florence Tubach; Philippe Ravaud; Dorcas Beaton; Maarten Boers; Claire Bombardier; David T Felson; Desireé van der Heijde; George Wells; Maxime Dougados
Journal:  J Rheumatol       Date:  2007-05       Impact factor: 4.666

6.  Deriving clinically meaningful cut-scores for fatigue in a cohort of breast cancer survivors: a Health, Eating, Activity, and Lifestyle (HEAL) Study.

Authors:  Angela M Stover; Bryce B Reeve; Barbara F Piper; Catherine M Alfano; Ashley Wilder Smith; Sandra A Mitchell; Leslie Bernstein; Kathy B Baumgartner; Anne McTiernan; Rachel Ballard-Barbash
Journal:  Qual Life Res       Date:  2013-02-19       Impact factor: 4.147

7.  Determination of the minimal clinically important difference for seven fatigue measures in rheumatoid arthritis.

Authors:  Jacques Pouchot; Raheem B Kherani; Rollin Brant; Diane Lacaille; Allen J Lehman; Stephanie Ensworth; Jacek Kopec; John M Esdaile; Matthew H Liang
Journal:  J Clin Epidemiol       Date:  2008-03-21       Impact factor: 6.437

8.  Fatigue with systolic heart failure.

Authors:  Anne M Fink; Shawna L Sullivan; Julie J Zerwic; Mariann R Piano
Journal:  J Cardiovasc Nurs       Date:  2009 Sep-Oct       Impact factor: 2.083

9.  Evaluation of clinically relevant changes in patient reported outcomes in knee and hip osteoarthritis: the minimal clinically important improvement.

Authors:  F Tubach; P Ravaud; G Baron; B Falissard; I Logeart; N Bellamy; C Bombardier; D Felson; M Hochberg; D van der Heijde; M Dougados
Journal:  Ann Rheum Dis       Date:  2004-06-18       Impact factor: 19.103

Review 10.  Physical activity.

Authors:  Anna L Schwartz
Journal:  Semin Oncol Nurs       Date:  2008-08       Impact factor: 2.315

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.